The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study

Inger-Lise Nesvold, Kristin Valborg Reinertsen, Sophie D Fosså, Alv A Dahl, Inger-Lise Nesvold, Kristin Valborg Reinertsen, Sophie D Fosså, Alv A Dahl

Abstract

Background: This cross-sectional and longitudinal study of breast cancer survivors (BCSs) examines the associations between arm/shoulder problems (ASPs), which consist of pain, restricted mobility and lymphedema, and different aspects of quality of life (QoL).

Methods: BCSs who had breast surgery, axillary lymph node dissection and radiotherapy (n = 255) were examined in 2004 (mean 4.1 years post-surgery) and a sub-sample (n = 187) was re-examined in 2007. ASPs was rated clinically in 2004 and by self-report (EORTC BR23) in 2004 and 2007. QoL was self-reported with The Short Form-36 (SF-36) and The Impact of Cancer scale (IOC).

Results: In 2004 BCSs with ASPs showed significantly poorer mean scores in most SF-36 domains compared to those without. No group differences were observed for positive IOC domains, while BCSs with ASPs showed significantly poorer mean scores in the negative ones. BCSs with clinically defined movement restriction showed significantly poorer SF-36 and negative IOC mean scores than those with clinically defined lymphedema. The longitudinal sub-study of self-rated pain, restricted mobility and lymphedema showed significant changes over time only for negative IOC domains in the pain group. Self-rated restricted mobility and lymphedema were significantly associated with most SF-36 domains both in 2004 and 2007, while few were associated with pain. Self-rated pain and restricted mobility showed significant associations with negative IOC domains.

Implications for cancer survivors: Not only lymphedema, but pain and restricted mobility in the arm/shoulder are significantly associated with poor QoL in BCSs at long-term. These problems should be diagnosed and treated in order to improve QoL.

Figures

Fig. 1
Fig. 1
Flowchart of the sample of the study

References

    1. Ahmed RL, Prizment A, Lazovich DA, Schmitz KH, Folsom AF. Lymphedema and quality of life in breast cancer survivors: The Iowa Women’s Health Study. J Clin Oncol. 2008;26:5689–96. doi: 10.1200/JCO.2008.16.4731.
    1. Norman SA, Russel Locario A, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390–97. doi: 10.1200/JCO.2008.17.9291.
    1. Nesvold IL, Dahl AA, Løkkevik E, Mengshoel AM, Fosså SD. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008;47:835–42. doi: 10.1080/02841860801961257.
    1. Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Møller S, et al. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain. 2009;13:478–85. doi: 10.1016/j.ejpain.2008.05.015.
    1. Sagen A, Kåresen R, Risberg MA. Changes in arm morbidities and health-related quality of life after breast cancer surgery—a five year follow-up study. Acta Oncol. 2009;48:1102–10. doi: 10.3109/02841860903061683.
    1. Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Ca Res. 2008;27:1–31. doi: 10.1186/1756-9966-27-1.
    1. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D. Axillary surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat. 2003;79:47–57. doi: 10.1023/A:1023330206021.
    1. Kwan W, Jackson J, Weir LM, Dingee C, McGregor Greg, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002;20:4242–48. doi: 10.1200/JCO.2002.09.018.
    1. Chachaj A, Malyszczak K, Pyszel K, Lukas J, Tarkowski R, Pudelko M, et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psycho-Oncol. 2010;19:299–305. doi: 10.1002/pon.1573.
    1. Pyszel A, Malyszczak K, Pyszel K, Andrejak R, Szuba A. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology. 2006;39:185–92.
    1. Bentzen SM, Overgaard AM, Thames HD. Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 1989;17:531–37. doi: 10.1016/0360-3016(89)90103-X.
    1. Mols F, Vingerthoets AJ, Coebergh JW, van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer. 2005;41:2613–19. doi: 10.1016/j.ejca.2005.05.017.
    1. Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psycho-Onco. 2006;15:407–21. doi: 10.1002/pon.963.
    1. Pearce NJM, Sanson-Fisher R, Campell HS. Measuring quality of life in cancer survivors:a methodological review of exisaitng scale. Psycho-Oncol. 2008;17:629–40. doi: 10.1002/pon.1281.
    1. Reinertsen KV, Cvankarova M, Wist E, Fosså SD, et al. Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample. Int J Radiat Oncol Biol Phys. 2009;75:764–70. doi: 10.1016/j.ijrobp.2008.11.037.
    1. Karges JR, Mark BE, Stikeleather SJ, Worrell TW. Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Therapy. 2003;83:134–45.
    1. Nesvold IL, Fosså SD, Naume B, Dahl AA. Kwan´s arm problem scale: psychometric examination in a sample of stage II breast cancer survivors. Breast Cancer Res Treat. 2008;117:281–88. doi: 10.1007/s10549-008-0288-7.
    1. Sprangers MAG, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756–68.
    1. Ware JE, Snow KK, Kosinski M, et al. SF-36® health survey: manual and interpretation guide. Lincoln: Quality Metric Inc; 2000.
    1. Ware JE, Gandek B, Kosinski M, et al. The equivalence of the SF-36 summary health scores estimating using standard and country-specific algorithms in 10 countries: results from the IQOLA project. J Clin Epidemiol. 1998;11:1167–70. doi: 10.1016/S0895-4356(98)00108-5.
    1. Lipsey MW, Wilson DB. Practical meta-analysis Thousand Oaks. CA: Sage; 2001.
    1. Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev. 2007;82:591–605. doi: 10.1111/j.1469-185X.2007.00027.x.
    1. Cohen J. Statistical power analysis for the behavioral sciences. 2. Hillsdale: Earlbaum; 1988.
    1. Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MAG, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Quality of Life Res. 2006;15:1533–50. doi: 10.1007/s11136-006-0025-9.
    1. Thomas-Maclean RL, Hack T, Kwan W, Towers A, Miedema B, Tilley A. Arm morbidity and disability after breast cancer: new directions of care. Oncol Nurs Forum. 2008;35:65–71. doi: 10.1188/08.ONF.65-71.
    1. Smoot B, Wong J, Cooper B, Wanec L, Topp K, Byl N, et al. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv 2010;4:167–78.
    1. Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Kreienberg R, et al. Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 2000;64:275–86. doi: 10.1023/A:1026564723698.
    1. Lauridsen MC, Overgaard M, Overgaard J, Hessow IB, Christiansen P. Shoulder disability and late symptoms following surgery for early breast cancer. Acta Oncol. 2008;47:569–75. doi: 10.1080/02841860801986627.
    1. Levangie PK, Drouin J. Magnitude of late effects of breast cancer treatment on shoulder function: a systematic review. Breast Cancer Res Treat. 2009;116:1–15. doi: 10.1007/s10549-008-0246-4.
    1. Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, Yarnold JR. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2010;11:231–40. doi: 10.1016/S1470-2045(09)70382-1.
    1. Liu C, Guo Y, Shi J, Sheng Y. Late morbidity associated with a tumour-negative sentinel lymph-node biopsy in primary breast cancer patients: a systematic review. Eur J Cancer. 2009;45:1560–8. doi: 10.1016/j.ejca.2009.02.012.
    1. Vignes S, Arrault M, Dupuy A. Factors associated with increased breast cancer-related lymphedema volume. Acta Oncol. 2007;46:1138–42. doi: 10.1080/02841860701403020.
    1. Koul R, Dufan T, Russell C, Guenther W, Nugent Z, Sun X, et al. Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer. Int J Radiat Oncol Biol Phys. 2007;67:841–46. doi: 10.1016/j.ijrobp.2006.09.024.
    1. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609. doi: 10.1093/jnci/djj158.
    1. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results form a randomized controlled trial. J Clin Oncol. 2005;23:4312–21. doi: 10.1200/JCO.2005.03.228.
    1. McNeely ML, Campbell K, Ospina M, Rowe BH, Dabbs K, Klassen TP, et al. Exercise interventions for upper-limb dysfunction due to breast cancer treatment (Review). 2010; The Cochrane Collaboration.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe